This NAMD letter responds to a supplemental proposed rule from the Substance Abuse and Mental Health Services Administration on the privacy requirements for substance use disorder (SUD) information (42 CFR Part 2). The letter underscores that separate privacy requirements for SUD information continue to prevent high quality, coordinated care for beneficiaries. It also makes recommendations […]
This letter outlines Medicaid Directors’ ongoing concerns with CMS’s interpretation of the Medicaid managed care rule’s Institutions for Mental Diseases (IMD) provisions, and makes recommendations to enhance flexibility and streamline implementation of these provisions. Read full letter.
NAMD’s legislative and regulatory priority documents outline opportunities to modernize the federal rules governing Medicaid to ensure these comport with the realities and expectations for states to run high performing Medicaid programs. NAMD believes these modernizations – in federal statute and in federal regulation – can have a meaningful, positive impact for Medicaid enrollees. See […]
NAMD notified the Center for Medicare and Medicaid Services (CMS), of its strong support for a next generation SIM initiative to continue building state capacity to lead the movement to a value-based health care system. Read full letter.
This memo provides background information for interested congressional staff on the IMD exclusion in light of the Center for Medicare and Medicaid Innovation’s (CMMI) recent decision not to extend the Medicaid Emergency Psychiatric Demonstration (MEPD). This document examines the context for the IMD exclusion; explores the available pathways for states to mitigate the IMD exclusion […]
NAMD provided comments to leaders of the House Energy and Commerce Committee on their draft proposal to establish a pediatric health home option for Medicaid children with medically complex conditions. Read full letter.
NAMD sent a letter to House of Representatives leadership on the need to address the privacy laws governing substance use disorder information as part of opioid legislation under consideration in the House. The letter underscores the need to amend the privacy laws of 42 CFR Part 2 to fully address the opioid crisis, and ensure […]
On April 29, NAMD sent a letter to leadership of the Senate Finance Committee and the Senate Health, Education, Labor, and Pensions Committee addressing Senators’ efforts to improve the nation’s behavioral health system. In particular, NAMD praised the Committees for their consideration of lifting restrictions on federal Medicaid payments for services provided in Institutions for […]